The breakdown of the molecular subtypes was as follows: POLE mutation in 11 cases (12.2%), MMR deficiency (MMRd) in 19 cases (21.1%), p53 abnormality in 6 cases (6.7%), and No Specific Molecular Profile (NSMP) in 54 cases (60%). The gene discussed is TP53; the disease is mismatch repair cancer syndrome 1.